SōRSE partners with Pascal Biosciences to begin a cannabinoid-based cancer therapy clinical trial

0 views
0%

SōRSE Technology CEO Howard Lee tells Proactive the privately-held Seattle-based company has partnered with Canadian biotech Pascal Biosciences to …

From:
Date: December 26, 2020

Leave a Reply

Your email address will not be published.